{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:00:41Z","timestamp":1787655641920,"version":"build-2736575974"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.00961","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T04:25:51Z","timestamp":1569471951000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy"],"prefix":"10.3389","volume":"9","author":[{"given":"Christina","family":"Schr\u00f6der","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Stahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Weder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"F\u00f6rster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Lauk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jso.1143","article-title":"Survival after conservative (palliative) management of pleural malignant mesothelioma","volume":"78","author":"Merritt","year":"2001","journal-title":"J Surg Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.thorsurg.2004.06.011","article-title":"Epidemiology, biologic behavior, and natural history of mesothelioma","volume":"14","author":"Zellos","year":"2004","journal-title":"Thorac Surg Clin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"Tsao","year":"2009","journal-title":"J Clin Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3978\/j.issn.2225-319X.2012.11.12","article-title":"Multimodality therapy for malignant pleural mesothelioma","volume":"1","author":"Weder","year":"2012","journal-title":"Ann Cardiothorac Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3109\/02841869609109921","article-title":"Radiosensitivity of mesothelioma cell lines","volume":"35","author":"Hakkinen","year":"1996","journal-title":"Acta Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lungcan.2013.10.013","article-title":"Radical pleurectomy\/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up","volume":"83","author":"Minatel","year":"2014","journal-title":"Lung Cancer."},{"key":"B8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijrobp.2014.08.343","article-title":"Hemithoracic intensity modulated radiation therapy after pleurectomy\/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis","volume":"91","author":"Chance","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/S1470-2045(15)00208-9","article-title":"Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomised, international, multicentre phase 2 trial","volume":"16","author":"Stahel","year":"2015","journal-title":"Lancet Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J Clin Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/ejcts\/ezv398","article-title":"Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma","volume":"49","author":"Kostron","year":"2016","journal-title":"Eur J Cardiothorac Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ijrobp.2011.08.036","article-title":"Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study","volume":"83","author":"Milano","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.lungcan.2016.04.012","article-title":"Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group \u201cstereotactic radiotherapy\u201d","volume":"97","author":"Rieber","year":"2016","journal-title":"Lung Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase ii, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/j.ijrobp.2018.06.187","article-title":"Phase I Trial of Stereotactic Body Radiation Therapy (SBRT) to multiple metastatic sites: a NRG Oncology Study","volume":"102","author":"Chmura","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/ejcts\/ezr263","article-title":"Cyberknife radiosurgery for focal paravertebral recurrence after radical pleurectomy\/decortication in malignant pleural mesothelioma","volume":"41","author":"Lang-Lazdunski","year":"2012","journal-title":"Eur J Cardiothorac Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00066-003-1055-7","article-title":"Stereotactic intensity-modulated radiation therapy (IMRT) and inverse treatment planning for advanced pleural mesothelioma. Feasibility and initial results","volume":"179","author":"Munter","year":"2003","journal-title":"Strahlenther Onkol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2005.03.031","article-title":"Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: the Heidelberg experience","author":"Munter","year":"2005","journal-title":"Lung Cancer."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00961\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T04:25:53Z","timestamp":1569471953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00961\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":21,"alternative-id":["10.3389\/fonc.2019.00961"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.00961","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,26]]},"article-number":"961"}}